SCHEMBL26101331

SCHEMBL26101331

CCOC(=O)c1cn(C2CC2)nc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
ELANE P08246 1/20 0.40
LMNA P02545 2/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
CSNK1D P48730 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 1/20 0.38
DGAT1 O75907 1/20 0.38
GRK6 P43250 1/20 0.38
BAZ2B Q9UIF8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6035727 0.93 LMNA (0.45) TSHRLMNAAKR1C3AKR1C2CSNK1D
SCHEMBL21816295 0.87 TSHR (0.42) TSHRELANELMNAAKR1C3AKR1C2
SCHEMBL1407155 0.84 BAZ2B (0.43) TSHRELANELMNAAKR1C3AKR1C2
SCHEMBL22897230 0.84 TSHR (0.40) TSHRELANELMNAAKR1C3AKR1C2
SCHEMBL1407095 0.84 CSNK1D (0.46) TSHRELANELMNAAKR1C3AKR1C2
SCHEMBL22979644 0.84 TSHR (0.40) TSHRELANELMNAAKR1C3AKR1C2
SCHEMBL21570236 0.83 TSHR (0.39) TSHRELANELMNAAKR1C3AKR1C2
SCHEMBL23728662 0.82 ADORA2A (0.38) TSHRCSNK1DNPC1RAB9AALDH1A1
SCHEMBL25162925 0.82 ADORA2A (0.38) TSHRCSNK1DNPC1RAB9AALDH1A1
SCHEMBL12984395 0.82 DGAT1 (0.52) TSHRELANELMNAALDH1A1DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132127-A1 NOVEL SPIRO COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2026-05-14 US disclosed
CN-118176179-A Novel spiro compounds 田边三菱制药株式会社 2024-06-11 CN disclosed
WO-2023074847-A1 NOVEL SPIRO COMPOUND 田辺三菱製薬株式会社 2023-05-04 WO disclosed
WO-2023074847-A1 NOVEL SPIRO COMPOUND 田辺三菱製薬株式会社 2023-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132127-A1 NOVEL SPIRO COMPOUND TRHR, NR3C2, THRB TSHR 10/4885ELANE 2932/4885LMNA 2025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.